CLADRIBINE(2-CDA) AND CYTARABINE(ARA-C) IS AN EFFECTIVE SALVAGE REGIMEN IN REFRACTORY/RELAPSED ACUTE MYELOID LEUKAEMIA IN CHILDREN

被引：0
|
作者：
Chinnaswamy, Girish [1 ]
Prasad, Maya [1 ]
Dwivedi, Pankaj [1 ]
Patil, Vijay [1 ]
Arora, Brijesh [1 ]
Banavali, Shripad [1 ]
机构：
[1] Tata Mem Hosp, Dept Med Oncol Pediat, Mumbai 400012, Maharashtra, India
来源：
PEDIATRIC BLOOD & CANCER | 2012年 / 59卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1040 / 1040
页数：1
相关论文
共 50 条
  • [21] A phase Ib study of oral panobinostat (LBH589) in combination with cytarabine (ARA-C) and mitoxantrone (MT) as salvage therapy for refractory or relapsed acute myeloid leukemia (AML)
    Krauter, J.
    Ottmann, O. G.
    Schlenk, R. F.
    Schaich, M.
    Bouscary, D.
    Dombret, H.
    Luedicke, F.
    Weber, H. J.
    Winiger, I. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [22] Cladribine, cytarabine, and filgrastim based regimen in relapsed or refractory acute myeloid leukemia: A systematic review and meta-analysis
    Cao, Susu
    Tao, Qianshan
    Wang, Jia
    Zhang, Qing
    Dong, Yi
    MEDICINE, 2023, 102 (44) : E34949
  • [23] Fludarabine, Cytarabine (ARA-C) and Pegylated Erwinase (PEGCRISANTASPASE) in Patients with Relapsed or Refractory Leukemia
    Almanza, Emmanuel
    Bataller, Alex
    Garcia-Manero, Guillermo
    Maiti, Abhishek
    Montalban-Bravo, Guillermo
    Takahashi, Koichi
    Short, Nicholas J.
    Jabbour, Elias
    Ravandi, Farhad
    Valero, Yesid Alvarado
    Kadia, Tapan M.
    BLOOD, 2023, 142
  • [24] Effective salvage therapy for high-risk relapsed or refractory acute myeloid leukaemia with cisplatin in combination with high-dose cytarabine and etoposide
    Lee, Yun-Gyoo
    Kwon, Ji-hyun
    Kim, Inho
    Yoon, Sung Soo
    Lee, Jong-Seok
    Park, Seongyang
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 92 (06) : 478 - 484
  • [25] Successful Salvage Treatment With Clofarabine and Cytarabine In Relapsed/Refractory Acute Myeloid Leukemia
    Malato, Alessandra
    Acquaviva, Francesco
    Santoro, Alessandra
    Felice, Rosaria
    Magrin, Silvana
    Turri, Diamante
    Scime, Rosanna
    Di Bella, Raimondo
    Salemi, Domenico
    Fabbiano, Francesco
    BLOOD, 2013, 122 (21)
  • [26] Modified cladribine, cytarabine, and G-CSF as a salvage regimen in patients with relapsed/refractory acute myeloid leukemia: a bridge to myeloablative allogeneic hematopoietic stem cell transplantation
    Ye, Peipei
    Pei, Renzhi
    Jin, Jie
    Sun, Jie
    Li, Kongfei
    Cao, Junjie
    Zhou, Dandan
    Lu, Ying
    ANNALS OF HEMATOLOGY, 2019, 98 (09) : 2073 - 2080
  • [27] Modified cladribine, cytarabine, and G-CSF as a salvage regimen in patients with relapsed/refractory acute myeloid leukemia: a bridge to myeloablative allogeneic hematopoietic stem cell transplantation
    Peipei Ye
    Renzhi Pei
    Jie Jin
    Jie Sun
    Kongfei Li
    Junjie Cao
    Dandan Zhou
    Ying Lu
    Annals of Hematology, 2019, 98 : 2073 - 2080
  • [28] Cladribine Combined with Idarubicin and Ara-C (CLIA) As a Frontline and Salvage Treatment for Young Patients (≤65 yrs) with Acute Myeloid Leukemia
    Jain, Preetesh
    Kantarjian, Hagop M.
    Ravandi, Farhad
    Jabbour, Elias
    Daver, Naval
    Pemmaraju, Naveen
    DiNardo, Courtney D.
    Alvarado, Yesid
    Jain, Nitin
    Borthakur, Gautam
    Verstovsek, Srdan
    Ferrajoli, Alessandra
    Ohanian, Maro
    Konopleva, Marina
    Naqvi, Kiran
    Fitch, Tina
    Garcia-Manero, Guillermo
    Cortes, Jorge E.
    Estrov, Zeev
    Kadia, Tapan M.
    BLOOD, 2016, 128 (22)
  • [29] Cladribine, cytarabine and idarubicin (CLA-Ida) salvage chemotherapy in relapsed acute myeloid leukemia (AML)
    Fridle, Chantal
    Medinger, Michael
    Wilk, Matthias C.
    Seipel, Katja
    Passweg, Jakob
    Manz, Markus G.
    Pabst, Thomas
    LEUKEMIA & LYMPHOMA, 2017, 58 (05) : 1068 - 1075
  • [30] Combination regimen of cladribine (2-chlorodeoxyadenosine), cytarabine and G-CSF (CLAG) as induction therapy for patients with relapsed or refractory acute myeloid leukemia
    Robak, T
    Wrzesien-Kus, A
    Lech-Maranda, E
    Kowal, M
    Dmoszynska, A
    LEUKEMIA & LYMPHOMA, 2000, 39 (1-2) : 121 - 129
12345